These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20356496)

  • 41. Fecal occult blood testing: a false sense of security?
    Schnell T; Aranha GV; Sontag SJ; Tode R; Reid S; Chejfec G; Karpf J; Levine G
    Surgery; 1994 Oct; 116(4):798-802; discussion 802-3. PubMed ID: 7940181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient perceptions of stool-based DNA testing for colorectal cancer screening.
    Schroy PC; Heeren TC
    Am J Prev Med; 2005 Feb; 28(2):208-14. PubMed ID: 15710277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT.
    Clavarino AM; Janda M; Hughes KL; Del Mar C; Tong S; Stanton WR; Aitken JF; Leggett BA; Newman B
    Prev Med; 2004 Sep; 39(3):482-90. PubMed ID: 15313087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnosis of colorectal carcinoma. An update].
    Schneider AR; Caspary WF
    Radiologe; 2003 Feb; 43(2):105-12. PubMed ID: 12624667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for colorectal cancer.
    Saliangas K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A population-based estimate of the extent of colorectal cancer screening in Ontario.
    Rabeneck L; Paszat LF
    Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of self-reported history of colorectal cancer screening.
    Khoja S; McGregor SE; Hilsden RJ
    Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attitudes, knowledge and practice of CRC screening among GPs in Queensland.
    Youl PH; Jackson C; Oldenburg B; Brown C; Dunn J; Aitken J
    Aust Fam Physician; 2006 Jul; 35(7):547-50. PubMed ID: 16820832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
    Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
    Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mass screening for colorectal cancer: compliance in Almopea Region.
    Chrissidis T; Saliangas K; Economou A; Nikoloudis N; Andreadis E; Prodromou K; Georgakis K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s193-5. PubMed ID: 15655620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
    Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
    J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Precautions for intestinal cancer in the workplace. An initiative for secondary prevention in the BASF joint-stock company].
    Webendörfer S; Messerer P; Eberle F; Zober A
    Dtsch Med Wochenschr; 2004 Feb; 129(6):239-43. PubMed ID: 14750049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Screening of the sporadic colorectal cancer].
    Zavoral M; Závada F
    Cas Lek Cesk; 2007; 146(12):950-4. PubMed ID: 18257413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of communicating social comparison information on risk perceptions for colorectal cancer.
    Lipkus IM; Klein WM
    J Health Commun; 2006 Jun; 11(4):391-407. PubMed ID: 16720537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Primary evaluation of a mass screening program for colorectal tumor in China].
    Huang YQ; Cai SR; Zhang SZ; Li QL; Ma XY; He YF; Zhou XH; Zheng S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jul; 45(7):601-4. PubMed ID: 22041562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effectiveness of the FLU-FOBT program in primary care a randomized trial.
    Potter MB; Walsh JM; Yu TM; Gildengorin G; Green LW; McPhee SJ
    Am J Prev Med; 2011 Jul; 41(1):9-16. PubMed ID: 21665058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Participation in colorectal cancer screening with FOBT and colonoscopy: an Italian, multicentre, randomized population study.
    Lisi D; Hassan C; Crespi M;
    Dig Liver Dis; 2010 May; 42(5):371-6. PubMed ID: 19747888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
    Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
    Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.